• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织转谷氨酰胺酶将 TGF-β、上皮到间充质转化和卵巢癌中的干细胞表型联系在一起。

Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.

机构信息

Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.

DOI:10.1038/onc.2011.429
PMID:21963846
Abstract

Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we show that transforming growth factor (TGF)-β, a cytokine involved in tumor dissemination is abundantly secreted in the OC microenvironment and induces TG2 expression and enzymatic activity. This is mediated at transcriptional level by SMADs and by TGF-β-activated kinase 1-mediated activation of the nuclear factor-κB complex. TGF-β-stimulated OC cells aggregate as spheroids, which enable peritoneal dissemination. We show that TGF-β-induced TG2 regulates EMT, formation of spheroids and OC metastasis. TG2 knock-down in OC cells decreases the number of cells harboring a cancer stem cell phenotype (CD44+/CD117+). Furthermore, CD44+/CD117+ cells isolated from human ovarian tumors express high levels of TG2. In summary, TGF-β-induced TG2 enhances ovarian tumor metastasis by inducing EMT and a cancer stem cell phenotype.

摘要

组织转谷氨酰胺酶(TG2)是一种参与细胞增殖、分化和凋亡的酶,在卵巢癌中过度表达,它调节上皮间质转化(EMT)并促进转移。其在卵巢癌(OC)中的调节尚不清楚。在这里,我们表明,转化生长因子(TGF)-β,一种参与肿瘤扩散的细胞因子,在 OC 微环境中大量分泌,并诱导 TG2 的表达和酶活性。这是通过 SMADs 在转录水平上介导的,以及通过 TGF-β激活激酶 1 介导的核因子-κB 复合物的激活。TGF-β 刺激的 OC 细胞聚集形成球体,从而实现腹膜扩散。我们表明,TGF-β 诱导的 TG2 调节 EMT、球体形成和 OC 转移。OC 细胞中的 TG2 敲低会减少具有癌症干细胞表型(CD44+/CD117+)的细胞数量。此外,从人卵巢肿瘤中分离的 CD44+/CD117+细胞表达高水平的 TG2。总之,TGF-β 诱导的 TG2 通过诱导 EMT 和癌症干细胞表型增强卵巢肿瘤转移。

相似文献

1
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.组织转谷氨酰胺酶将 TGF-β、上皮到间充质转化和卵巢癌中的干细胞表型联系在一起。
Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.
2
Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.细胞外组织转谷氨酰胺酶激活非典型 NF-κB 信号通路并促进卵巢癌转移。
Neoplasia. 2013 Jun;15(6):609-19. doi: 10.1593/neo.121878.
3
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.组织转谷氨酰胺酶诱导的上皮间质转化与卵巢肿瘤进展。
Cancer Res. 2009 Dec 15;69(24):9192-201. doi: 10.1158/0008-5472.CAN-09-1257.
4
Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.组织转谷氨酰胺酶诱导大肠癌细胞发生上皮-间质转化并获得干细胞样特征。
Oncotarget. 2017 Mar 21;8(12):20025-20041. doi: 10.18632/oncotarget.15370.
5
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.PARP3通过刺激转谷氨酰胺酶2-蜗牛-E-钙黏蛋白轴来控制转化生长因子β和活性氧驱动的上皮-间质转化及干性。
Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
6
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.组织转谷氨酰胺酶通过 c-Src 依赖性机制调节β-连环蛋白信号通路。
FASEB J. 2013 Aug;27(8):3100-12. doi: 10.1096/fj.12-222620. Epub 2013 May 2.
7
Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.组织转谷氨酰胺酶通过诱导乳腺上皮细胞发生间质转化促进药物耐药和侵袭。
PLoS One. 2010 Oct 12;5(10):e13390. doi: 10.1371/journal.pone.0013390.
8
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.证据表明,转谷氨酰胺酶 2 的 GTP 结合结构域而非催化结构域对于乳腺上皮细胞中的上皮-间充质转化是必需的。
Breast Cancer Res. 2012 Jan 6;14(1):R4. doi: 10.1186/bcr3085.
9
Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.转谷氨酰胺酶 2 通过下调蛋白磷酸酶 2A 激活 c-Jun-N 端激酶诱导 TGF-β1 诱导的上皮间质转化中 N 钙粘蛋白的表达。
Eur J Cancer. 2013 May;49(7):1692-705. doi: 10.1016/j.ejca.2012.11.036. Epub 2013 Jan 2.
10
TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.TGF-β 介导的 LEFTY/Akt/GSK-3β/Snail 轴调节卵巢透明细胞癌中的上皮-间充质转化和癌症干细胞特性。
Mol Carcinog. 2018 Aug;57(8):957-967. doi: 10.1002/mc.22816. Epub 2018 Apr 15.

引用本文的文献

1
Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.转谷氨酰胺酶2刺激肝癌细胞增殖并独立于上皮-间质转化调节转化生长因子-β信号通路。
Int J Mol Sci. 2025 Jun 8;26(12):5497. doi: 10.3390/ijms26125497.
2
USP9X integrates TGF-β and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2α-maintained stemness.USP9X整合转化生长因子-β和缺氧信号,通过HIF-2α维持的干性来促进卵巢癌化疗耐药性。
Cell Death Dis. 2025 Apr 18;16(1):312. doi: 10.1038/s41419-025-07646-5.
3
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
纳入基因组分析和聚(ADP-核糖)聚合酶-1 表达的肺高级别神经内分泌癌的预后模型。
JCO Precis Oncol. 2024 Apr;8:e2300495. doi: 10.1200/PO.23.00495.
4
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses.双靶融合蛋白 bintrafusp alfa 通过抑制 TGF-β 和 PD-L1 促进 T 效应细胞和 NK 细胞应答,从而提高临床前卵巢癌模型的存活率。
Br J Cancer. 2024 Jun;130(12):2003-2015. doi: 10.1038/s41416-024-02677-9. Epub 2024 Apr 15.
5
Mesenchymal Transglutaminase 2 Activates Epithelial ADAM17: Link to G-Protein-Coupled Receptor 56 (ADGRG1) Signalling.间质转谷氨酰胺酶 2 激活上皮 ADAM17:与 G 蛋白偶联受体 56(ADGRG1)信号的联系。
Int J Mol Sci. 2024 Feb 16;25(4):2329. doi: 10.3390/ijms25042329.
6
FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.FBXO28 通过上调 TGF-β1/SMAD2/3 信号通路促进卵巢癌细胞增殖、迁移和侵袭。
BMC Cancer. 2024 Jan 24;24(1):122. doi: 10.1186/s12885-024-11893-8.
7
The Role of Cancer Stem Cell Markers in Ovarian Cancer.癌症干细胞标志物在卵巢癌中的作用
Cancers (Basel). 2023 Dec 20;16(1):40. doi: 10.3390/cancers16010040.
8
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.定义转移起始细胞在促进卵巢癌发生中的作用。
Biology (Basel). 2023 Dec 5;12(12):1492. doi: 10.3390/biology12121492.
9
Transglutaminase 2 Facilitates Murine Wound Healing in a Strain-Dependent Manner.转谷氨酰胺酶 2 以应变依赖的方式促进小鼠伤口愈合。
Int J Mol Sci. 2023 Jul 14;24(14):11475. doi: 10.3390/ijms241411475.
10
Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2).靶向组织转谷氨酰胺酶(TG2)的 PROTACs 的发现和表征。
J Med Chem. 2023 Jul 27;66(14):9445-9465. doi: 10.1021/acs.jmedchem.2c01859. Epub 2023 Jul 14.